{"id":159626,"date":"2024-06-04T03:46:07","date_gmt":"2024-06-04T03:46:07","guid":{"rendered":"https:\/\/dailytalks.org\/?p=159626"},"modified":"2024-06-04T03:46:07","modified_gmt":"2024-06-04T03:46:07","slug":"nxera-pharma-announces-supply-and-distribution-deal-with-handok-for-pivlaz-in-south-korea","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=159626","title":{"rendered":"Nxera Pharma Announces Supply And Distribution Deal With Handok For PIVLAZ In South Korea"},"content":{"rendered":"<p>RTTNews) &#8211; Nxera Pharma Co. Ltd, formerly known as Sosei Group, announced that its operating business Nxera Pharma Korea has reached an exclusive supply and distribution agreement with Handok Inc. to commercialize PIVLAZ (clazosentan sodium) 150 mg in South Korea&#8230;<br \/><a href=\"https:\/\/www.nasdaq.com\/articles\/nxera-pharma-announces-supply-and-distribution-deal-with-handok-for-pivlaz-in-south-korea\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>RTTNews) &#8211; Nxera Pharma Co. Ltd, formerly known as Sosei Group, announced that its operating<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-159626","post","type-post","status-publish","format-standard","hentry","category-breaking"],"featured_image_urls":{"full":"","thumbnail":"","medium":"","medium_large":"","large":"","1536x1536":"","2048x2048":"","chromenews-featured":"","chromenews-large":"","chromenews-medium":""},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=14\" rel=\"category\">BREAKING NEWS<\/a>","tag_info":"BREAKING NEWS","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/159626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=159626"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/159626\/revisions"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=159626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=159626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=159626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}